Return to Home Mortality > Table > Data Table

Data Table for Rate/Trend Comparison by State/County

Death Rate/Trend Comparison by State/County, 2016-2020

Indiana versus United States

All Races, Both Sexes

Sorted by priority index
Cancer Site and Sex
 sort alphabetically by cancer site ascending
Priority Index1
1=highest
9=lowest

 sort by priority index ascending
Recent Trend2
County Death
Rate
Compared
to
US Rate
Average Annual Count
 sort by count descending
Age-Adjusted Death Rate

deaths per 100,000
(95% Confidence Interval)
 sort by rate descending
Rate
Ratio3
County
to
US
 sort by rate descending
Recent 5-Year Trend2 in Death Rates
(95% Confidence Interval)
 sort by trend descending
Stomach (Female) 9 falling falling trend lower 69 1.6 (1.4, 1.8) 0.8 -2.2 (-2.6, -1.8)
Stomach (Male) 9 falling falling trend lower 114 3.2 (2.9, 3.5) 0.8 -2.4 (-2.8, -2.0)
Brain & ONS (Female) 8 falling falling trend similar 153 3.6 (3.4, 3.9) 1.0 -0.5 (-0.9, -0.1)
Brain & ONS (Male) 8 falling falling trend similar 202 5.5 (5.2, 5.9) 1.0 -0.3 (-0.6, 0.0)
Breast (Female) 8 falling falling trend similar 892 20.4 (19.8, 21.1) 1.0 -1.7 (-1.9, -1.6)
Childhood (Ages <15, All Sites) (Male) 8 falling falling trend similar 13 2.0 (1.5, 2.5) 0.9 -1.4 (-2.4, -0.3)
Childhood (Ages <20, All Sites) (Female) 8 falling falling trend similar 15 1.7 (1.3, 2.2) 0.9 -1.1 (-2.2, -0.1)
Childhood (Ages <20, All Sites) (Male) 8 falling falling trend similar 21 2.3 (1.9, 2.8) 1.0 -1.6 (-2.4, -0.8)
Colon & Rectum (Female) 8 falling falling trend similar 555 12.4 (11.9, 12.9) 1.1 -1.6 (-2.5, -0.6)
Colon & Rectum (Male) 8 falling falling trend similar 616 17.4 (16.8, 18.0) 1.1 -2.6 (-2.9, -2.2)
Kidney & Renal Pelvis (Male) 8 falling falling trend similar 197 5.6 (5.2, 5.9) 1.1 -0.9 (-1.3, -0.5)
Leukemia (Female) 8 falling falling trend similar 215 4.9 (4.6, 5.2) 1.1 -2.7 (-4.0, -1.3)
Leukemia (Male) 8 falling falling trend similar 298 8.9 (8.4, 9.3) 1.1 -1.9 (-2.8, -1.0)
Non-Hodgkin Lymphoma (Female) 8 falling falling trend similar 201 4.5 (4.2, 4.7) 1.1 -2.6 (-3.1, -2.2)
Non-Hodgkin Lymphoma (Male) 8 falling falling trend similar 260 7.6 (7.2, 8.0) 1.1 -2.2 (-2.7, -1.7)
Ovary (Female) 8 falling falling trend similar 279 6.3 (5.9, 6.6) 1.0 -3.0 (-3.7, -2.3)
Bladder (Female) 6 stable stable trend similar 103 2.2 (2.0, 2.4) 1.1 -0.3 (-0.7, 0.2)
Bladder (Male) 6 stable stable trend similar 263 7.9 (7.5, 8.3) 1.1 -0.1 (-0.4, 0.2)
Esophagus (Female) 6 stable stable trend similar 70 1.5 (1.4, 1.7) 1.1 -0.1 (-0.5, 0.4)
Melanoma of the Skin (Female) 6 stable stable trend similar 63 1.5 (1.3, 1.7) 1.1 -0.5 (-1.2, 0.3)
Oral Cavity & Pharynx (Female) 6 stable stable trend similar 65 1.5 (1.3, 1.6) 1.1 2.1 (-0.5, 4.8)
Prostate (Male) 6 stable stable trend similar 636 19.5 (18.9, 20.3) 1.0 0.1 (-1.6, 1.8)
Thyroid (Female) 6 stable stable trend similar 26 0.6 (0.5, 0.7) 1.2 0.9 (0.0, 1.9)
Kidney & Renal Pelvis (Female) 5 falling falling trend higher 124 2.7 (2.5, 3.0) 1.3 -1.0 (-1.4, -0.6)
Lung & Bronchus (Female) 5 falling falling trend higher 1,667 36.9 (36.1, 37.7) 1.3 -2.2 (-2.6, -1.8)
Lung & Bronchus (Male) 5 falling falling trend higher 2,031 55.3 (54.2, 56.4) 1.3 -3.9 (-4.4, -3.4)
Melanoma of the Skin (Male) 5 falling falling trend higher 124 3.6 (3.3, 3.9) 1.2 -2.7 (-4.5, -0.8)
Liver & Bile Duct (Female) 2 rising rising trend similar 171 3.8 (3.6, 4.1) 0.9 1.7 (1.3, 2.2)
Liver & Bile Duct (Male) 2 rising rising trend similar 355 9.1 (8.6, 9.5) 0.9 2.1 (1.8, 2.5)
Oral Cavity & Pharynx (Male) 2 rising rising trend similar 157 4.2 (3.9, 4.5) 1.1 1.5 (0.5, 2.5)
Pancreas (Female) 2 rising rising trend similar 469 10.3 (9.9, 10.8) 1.1 0.5 (0.3, 0.7)
Pancreas (Male) 2 rising rising trend similar 510 13.9 (13.4, 14.5) 1.1 0.5 (0.2, 0.9)
Uterus (Corpus & Uterus, NOS) (Female) 2 rising rising trend similar 233 5.1 (4.8, 5.4) 1.0 0.6 (0.2, 0.9)
Cervix (Female) 1 rising rising trend higher 99 2.7 (2.5, 3.0) 1.2 1.7 (0.1, 3.4)
Esophagus (Male) 1 rising rising trend higher 329 8.8 (8.4, 9.2) 1.3 0.4 (0.1, 0.7)
Childhood (Ages <15, All Sites) (Female)
**
** similar 9 1.5 (1.1, 2.0) 0.8
**
Thyroid (Male)
**
** similar 17 0.5 (0.4, 0.6) 0.9
**
Notes:
Created by statecancerprofiles.cancer.gov on 04/19/2024 12:28 am.

Trend2
     Rising     when 95% confidence interval of average annual percent change is above 0.
     Stable     when 95% confidence interval of average annual percent change includes 0.
     Falling     when 95% confidence interval of average annual percent change is below 0.
Rate Comparison
     Above     when 95% confident the rate is above and Rate Ratio3 > 1.10
     Similar     when unable to conclude above or below with confidence.
     Below     when 95% confident the rate is below and Rate Ratio3 < 0.90

** Data are too sparse to provide stable estimates of annual rates needed to calculate trend.
1 Priority indices were created by ordering from rates that are rising and above the comparison rate to rates that are falling and below the comparison rate.
2 Recent trend in death rates is usually an Average Annual Percent Change (AAPC) based on the APCs calculated by Joinpoint Version 4.8.0.0. Due to data availability issues, the time period and/or calculation method used in the calculation of the trends may differ for selected geographic areas.
3 Rate ratio is the county rate divided by the US rate. Previous versions of this table used one-year rates for states and five-year rates for counties. As of June 2018, only five-year rates are used.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with mortality data.
Note: When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate. Suppression is used to avoid misinterpretation when rates are unstable.

State Cancer Registries may provide more current or more local data. Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries (for more information).
Trend for the following could not be reliably determined due to small number of deaths per year:
Childhood (Ages <15, All Sites) (Female), Thyroid (Male)


Interpret Rankings provides insight into interpreting cancer statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top